Sheridan, June 23, 2025 (GLOBE NEWSWIRE) -- According to the latest market report published by Wissen Research, the global digital diabetes management market was valued at 17.67 billion in 2024. Furthermore, the market is expected to grow at a CAGR of 14% during the forecast period from 2025 to 2030.
Digital Diabetes Management Market Report Pricing @ https://www.wissenresearch.com/Pricing/
Digital Diabetes Management Market Summary
| Digital Diabetes Management Market Report Attributes | Details |
| Digital Diabetes Management Market Size (2024) | USD 17.67 Billion |
| Digital Diabetes Management Market Size (2030) | USD 38.78 Billion |
| CAGR | 14% |
| Base Year | 2024 |
| Forecast Period | 2025-2030 |
| Regions Covered |
|
US Digital Diabetes Management Market Size
Further, the US held majority share in the global digital diabetes management market and is likely to remain the leading region growing a CAGR of 14.2% within this market, during the forecast period.
Growth Drivers
- A significant rise in diabetes cases globally
- Shift towards tele-health and remote patient monitoring solutions
- Increasing government initiatives and diabetes awareness programs
- Incorporation of AI and ML in diabetes management devices
- Increasing focus on personalized healthcare
- Growing awareness about diabetes management and the importance of lifestyle modifications
Opportunities
- Innovations in mobile health applications, wearables, & continuous glucose monitoring (CGM) systems
- Increased smartphone & wearable device usage
- Growing demand for remote monitoring
- Increased government initiatives & awareness programs
- Increased investment in healthcare infrastructure in emerging economies
Continuous glucose monitoring segment dominated the market due to rise in demand and cost-effectiveness and convenience
The continuous glucose monitoring (CGM) market led the market because of the increasing prevalence of diabetes globally, increasing usage of real-time and convenient monitoring of glucose levels, and the affordability of CGM systems over repeated finger-stick testing. CGMs provide continuous, automatic measurement of glucose levels, decreasing the risk of hypoglycemia and facilitating improved glycemic control, particularly beneficial for patients with diabetes being cared for at home or in remote communities.
For instance, the FDA-approved Dexcom Stelo Glucose Biosensor System—an over-the-counter CGM introduced in 2025—offers adults a simple-to-use, non-invasive tool to track glucose without insulin or regular blood draws, capturing the segment's potential for convenience and value. Such growth is also compounded by improving technology, enhanced health awareness, and wider insurance coverage, making CGM the cornerstone of contemporary diabetes care worldwide.
Wearable devices dominate digital diabetes management
The market for digital diabetes management is divided into handheld and wearable devices according to the type of device. Wearable devices own a significant share of this market thanks to a number of advances in this area. These are some of the developments undertaken here: the creation of closed-loop pump systems, smart insulin patches, and other emerging devices. Moreover, increasing use of smart insulin pumps and patches for self-injection of insulin has further driven the prevalence of wearable devices in diabetes management.
North America is projected to be the fastest-growing market
North America is likely to exhibit the highest CAGR of the digital diabetes management market, ahead of Europe, Asia Pacific, Latin America, and Middle East & Africa. This growth is fueled by a range of factors, such as the high uptake of connected diabetes management devices, rising use of diabetes and obesity management applications, high demand for technology-based solutions, larger acceptance of digital diabetes solutions from payers, government initiatives supporting digital health, and increasing awareness of self-diabetes care in the market.
BRAND ANALYSIS: DIGITAL DIABETES MANAGEMENT MARKET
| Product (CGM System) | Dexcom G7 (Dexcom, Inc.) | FreeStyle Libre 3 (Abbott Laboratories) | Eversense E3 (Senseonics, distributed by Ascensia Diabetes Care) |
| Sensor Wear Duration | Up to 10 days | Up to 14 days | Up to 180 days (implantable sensor) |
| Calibration Requirement | No routine calibration needed | No calibration required | 2 calibrations per day |
| Data Transmission | Real-time, continuous via Bluetooth to smartphone or receiver | Real-time, continuous via Bluetooth to smartphone | Real-time, continuous via transmitter to mobile app |
| Size & Form Factor | Small, slim, all-in-one wearable sensor | Thin, small sensor worn on back of upper arm | Implantable sensor with removable transmitter |
| Alerts & Alarms | Customizable high/low glucose alerts, predictive alerts | Customizable high/low glucose alerts | Predictive alerts, on-body vibration alerts |
| Integration | Compatible with select insulin pumps and digital diabetes apps | Integrates with digital health apps, some pump compatibility | Integrates with digital platforms, remote monitoring |
| Unique Differentiator | All-in-one sensor/transmitter, rapid warm-up, strong app ecosystem | Longest non-implantable sensor wear, cost-effective, broad access, smallest sensor in the market | Only long-term implantable CGM, suitable for users seeking fewer sensor changes |
| Pricing | $119.27 to $529.99 | $75.00 to $95.00 | $99.00 |
| Revenue | $ 4.03 Billion (Company revenue) | $ 6.8 Billion (Segmental revenue- Diabetes care) | $22.5 Million (Company revenue*) |
Note: *Senseonics Holdings, Inc. is a medical technology company focused on the development and manufacturing of glucose monitoring products, Eversense® 365 and Eversense® E3
Request Customized Report @ https://www.wissenresearch.com/ask-for-customization/
Contact us for free sample of digital diabetes management market report: https://www.wissenresearch.com/contact/
Other Latest Reports from Wissen Research
- Diagnostic Imaging Diagnostics Market
- Remote Patient Monitoring Market
- Radioactive Tracers Market
- Point of Care Testing Market
- In-Vitro Diagnostics Market
- Ophthalmic Equipment Market
About us
Wissen Research is a leading market research firm that serves over 800 clients, with 40% of the top 2,000 companies relying on us for insights into key business questions and the identification of new high-growth and niche revenue opportunities. We offer exclusive market intelligence from over 120 subject matter experts and analysts, complemented by our high-growth niche market studies and consulting services.
Our research methodology delivers quantifiable and actionable insights into interconnected market ecosystems shaped by disruptive technologies and emerging markets. We not only focus on factors that will impact our clients' revenue but also explore what could affect their customers' revenue by revealing latent and adjacent market opportunities.
We collaborate across all B2B sectors, engaging with C-level executives in areas such as R&D, intellectual property, strategy, marketing, sales, product development, and M&A.
